Novo Nordisk finds compounded Wegovy up to 33% impure, sues Florida pharmacies
By Patrick Wingrove (Reuters) -Novo Nordisk said on Thursday it sued one compounding pharmacy and refiled a lawsuit against another
2023-12-01 15:57
Macron to unveil 2.1 billion eur Novo Nordisk pharma investment in France
PARIS French President Emmanuel Macron will on Thursday inaugurate a 2.1 billion euro ($2.3 billion) investment by Danish
2023-11-23 13:18
Medical device makers rise on relief after Wegovy obesity trial data
Shares of U.S. medical device makers climbed in early trading on Monday as a potential hit from the
2023-11-13 23:45
Wegovy's heart benefits due to more than weight loss, Novo says
By Patrick Wingrove PHILADELPHIA (Reuters) -Novo Nordisk on Saturday said the heart protective benefits of its wildly popular Wegovy obesity
2023-11-12 22:57
Drugmaker Novo Nordisk seeks obesity, diabetes 'bolt-on' deals
By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN Novo Nordisk wants to buy more companies with drugs in early-
2023-11-10 19:20
Weight-loss drug maker Novo Nordisk invests $6 billion to boost output
COPENHAGEN Novo Nordisk said on Friday it will invest more than 42 billion crowns ($6 billion) in its
2023-11-10 17:27
Novo Nordisk flags continued restrictions on Wegovy supplies
COPENHAGEN (Reuters) -Novo Nordisk on Thursday reported record sales and operating profits for the third quarter but flagged continued restrictions
2023-11-02 14:55
Novo Nordisk in $1.3 billion deal to buy hypertension drug
COPENHAGEN Novo Nordisk has agreed to buy ocedurenone, a drug for uncontrolled hypertension with potential application in cardiovascular
2023-10-16 19:23
The maker of Wegovy and Ozempic is now Europe's most valuable company
Novo Nordisk has dethroned Bernard Arnault's luxury goods giant LVMH as Europe's most valuable company.
2023-09-05 19:21
Wegovy makes UK weight-loss debut even as Novo struggles with supplies
By Maggie Fick LONDON Some Britons are set to be able to get Wegovy weight-loss injections after Novo
2023-09-04 23:58
Drugmaker Novo Nordisk overtakes LVMH as Europe's most valuable company
By Lucy Raitano and Danilo Masoni LONDON (Reuters) -Danish drugmaker Novo Nordisk unseated LVMH as Europe's most valuable listed company
2023-09-02 00:27
Strong U.S. demand eases pressure on Novo to show weight-loss drug's health benefits
By Maggie Fick LONDON Soaring U.S. demand for Novo Nordisk's weight-loss drug has reduced the pressure from investors
2023-07-14 13:15